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Figure S1. Mutation frequencies in the injected F0 embryos. We evaluated the genome-editing activities of pax2a-gRNA1-3 by examining mutation frequencies in the gRNA/Cas9-injected F0 embryos. Mutation frequencies were determined using random sequencing of PCR amplified-fragments from genomic DNAs prepared from the injected F0 embryos. The target sequences are highlighted in yellow. Blue letters indicate PAM sequences. Deleted and inserted nucleotides are indicated by red dashes and red letters, respectively. The number of nucleotides deleted and inserted is indicated to the right with the detection number. Genomic sequence of the 5' junction and the 3' junction at the integration site in the eGFP-positive embryo. Inserted nucleotides are indicated in red letters. Black letters and green letters represent pax2a sequences and the reporter sequences, respectively. Figure S3 . Off-target effect in the pax2a-gRNAs/Cas9 injected embryos. Genomic fragments containing on-target (pax2a) and off-target sites (zp3a.2, shq1, chchd3a and slc2a11l) were amplified from genomic DNAs (uninjected, 1, 3, 5, 7, 9; 2, 4, 6, 8; 10) by PCR using individual locus-specific primers (Supplementary Table S4 ). Heteroduplexes were detected in the PCR amplicon for pax2a locus, but not in the PCR amplicons for zp3a.2, shq1, chchd3a and slc2a11l loci. Asterisks (*) and crosses (+) indicate heteroduplexes and non-specific bands, respectively.
5 Figure S4 . Sequence of the knock-in allele in the Tg[pax2a-hs:eGFP] embryo. A sequence analysis revealed that Mbait-hs-eGFP was integrated into the pax2a-target 2.
The pax2a-target 1 had a 7-bp deletion, and the pax2a-target 3 had no indel mutation. Table S4 ). The pax2a transcripts containing exon 1 and exon 2 were suppressed in the homozygous embryos, but not wild-type and the heterozygous embryos. The pax2a transcripts containing exon 3 and exon 4 were comparably detected in all embryos. The β-actin transcripts were amplified by RT-PCR using the β-actin-RT-PCR-F and the β-actin-RT-PCR-R primers (Supplementary Table   S4 ). PCR amplicons (86 bp) using pax2a-exon1-F2 and pax2a-exon2-R were separated by polyacrylamide gels, other PCR amplicons were separated by agarose gels.
8 Figure S6 . Genotyping of Tg[pax2a-hs:eGFP] F2 embryos obtained from mating heterozygous Tg[pax2a-hs:eGFP] F1 fish. We classified F2 embryos into three groups, groups; group 1, eGFP negative (eGFP-) and normal MHB; group 2, eGFP positive (eGFP+) and normal MHB; group 3, eGFP+ and no isthmus (noi) phenotype. Eight embryos in each group were genotyped. As the result of PCR-based genotyping using the pax2a-specific and reporter-specific primers (Fig. 1a) , we verified that group 1 was wild-type, group 2 was heterozygous Tg[pax2a-hs:eGFP], and group 3 was homozygous Tg[pax2a-hs:eGFP]. M; molecular weight marker. Total RNAs were prepared from wild-type (1-3), heterozygous Tg[epdr1-hs:eGFP] (4-5) and Tg[epdr1-hs:eGFP] homozygous (7-9) embryos. The epdr1 transcripts containing exon 1 and exon 2 were amplified by RT-PCR using the epdr1-exon1-F and the epdr1-exon2-R primers (Supplementary Table S4 ). The β-actin transcripts were amplified by RT-PCR using the β-actin-RT-PCR-F and the β-actin-RT-PCR-R primers (Supplementary Table S4 ). Table S4 ). The β-actin transcripts were amplified by PCR using the β-actin-RT-PCR-F and the β-actin-RT-PCR-R primers (Supplementary Table S4 
